Dec 16 - Regeneron Pharmaceuticals (REGN.O) has settled allegations that it misused a patented protein to test its COVID-19 treatment REGEN-COV, according to filings in New York federal court. U.S.
innovations to develop its blockbuster COVID-19 vaccine Spikevax. The lawsuit said Moderna uses Northwestern-developed lipid nanoparticle (LNP) technology without a license in Spikevax shots to transport
While the US on Tuesday refused to join the international effort to develop a COVID-19 vaccine, China is pooling efforts in international cooperation to secure a fair distribution of COVID-19
While the US on Tuesday refused to join the international effort to develop a COVID-19 vaccine, China is pooling efforts in international cooperation to secure a fair distribution of COVID-19
with its blockbuster COVID-19 vaccine Spikevax and RSV shot mResvia. According to the two lawsuits, Moderna's lipid nanoparticles for transporting fragile mRNA into the human body infringe several
LONDON, Sept 25 (Reuters) - Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the
A Covid 19 vaccine developed in Bangladesh has been granted a patent by the United States Patent and Trademark Office (USPTO), marking the first-ever U.S. pharmaceutical patent acquired by a
Chinese authorities have granted the first invention patent to a domestically developed COVID-19 vaccine candidate, which experts said demonstrates the vaccine's originality and creativity, and would
Chinese authorities have granted the first invention patent to a domestically developed COVID-19 vaccine candidate, which experts said demonstrates the vaccine's originality and creativity, and would
Chinese authorities have granted the first invention patent to a domestically developed COVID-19 vaccine candidate, which experts said demonstrates the vaccine's originality and creativity, and would